Drug Shortage Report for PMS-CYTARABINE

Last updated on 2020-06-08 History
Report ID 37250
Drug Identification Number 02406772
Brand name PMS-CYTARABINE
Common or Proper name CYTARABINE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) CYTARABINE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Packaging size 10ML
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-24
Estimated end date Unknown
Actual end date 2020-06-05
Shortage status Resolved
Updated date 2020-06-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-06-08 French Compare
v6 2020-06-08 English Compare
v5 2018-02-15 French Compare
v4 2018-02-15 English Compare
v3 2018-01-26 French Compare
v2 2018-01-26 English Compare
v1 2018-01-26 English Compare

Showing 1 to 7 of 7